Publication:
Biological Treatment Agents in the Psoriasis

dc.authorscopusid16554714900
dc.authorscopusid7004347982
dc.authorscopusid6603682965
dc.authorscopusid6601978714
dc.authorscopusid6603561910
dc.contributor.authorFindik, G.
dc.contributor.authorAydin, F.
dc.contributor.authorŞentürk, N.
dc.contributor.authorCantürk, T.
dc.contributor.authorTuranli, A.Y.
dc.date.accessioned2025-12-11T02:11:58Z
dc.date.issued2003
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Findik] Gül, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Aydin] Fatma, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şentürk] Nilgün, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Cantürk] Tayyar, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Turanli] Ahmet Yaşar, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe importance of immune system in pathogenesis of psoriasis have led to development of new therapeutic agents that selectively act on receptors, chemokines and cytokines to immune system. This article reviews recent developments in immune based therapies for psoriasis.en_US
dc.identifier.endpage216en_US
dc.identifier.issn1300-2996
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-11844297830
dc.identifier.scopusqualityN/A
dc.identifier.startpage211en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/47782
dc.identifier.volume20en_US
dc.identifier.wosqualityN/A
dc.language.isotren_US
dc.relation.ispartofOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiologic Therapyen_US
dc.subjectImmune Systemen_US
dc.subjectPsoriasisen_US
dc.titleBiological Treatment Agents in the Psoriasisen_US
dc.title.alternativePsoriasis Tedavisinde Biyolojik Ajanlaren_US
dc.typeArticleen_US
dspace.entity.typePublication

Files